P

Prothena Corp
D

PRTA

14.370
USD
0.26
(1.84%)
مغلق
حجم التداول
0
الربح لكل سهم
-4
العائد الربحي
-
P/E
-6
حجم السوق
773,231,479
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    ALNY
    ALNY
    1.73
    (0.65%)
    266.69 USD
    B
    BLUE
    -0.31000
    (-3.79%)
    7.86000 USD
    BMY
    BMY
    0.025
    (0.04%)
    57.075 USD
    GILD
    GILD
    0.070
    (0.08%)
    93.020 USD
    I
    IMUX
    0.03700
    (3.93%)
    0.97760 USD
    I
    INCY
    -1.050
    (-1.43%)
    72.420 USD
    MRNA
    MRNA
    2.600
    (7.24%)
    38.490 USD
    REGN
    REGN
    -7.47
    (-1.09%)
    679.85 USD
    VRTX
    VRTX
    0.08
    (0.02%)
    428.09 USD
    المزيد
الأخبار
المقالات

العنوان: Prothena Corp

القطاع: Healthcare
الصناعة: Biotechnology
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).